Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized…

Overview of attention for article published in BMC Cancer, October 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 2 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 456 followers.

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study. https://t.co/mYr8j6tzLM

28 Feb 2020

Reply Repost Favourite

26 Oct 2019

Reply Repost Favourite

25 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.